Adeshwar Meditex P/E Ratio
Current P/E Ratio
33.09
High Valuation
Very High - High growth expectations or significantly overvalued
Adeshwar Meditex (ADESHWAR) P/E ratio is 33.09 (High), EPS (TTM) ₹1.43, current price ₹ on None — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Adeshwar Meditex stock price NSE.
Current Valuation Metrics
P/E Ratio
33.09
Current Price
₹
EPS (TTM)
₹1.43
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
55.0
Sector Median
30.62
Sector Rank
#11 of 198
Sector Percentile
5.6%
ADESHWAR P/E Ratio — Valuation Signal & Historical Context
Adeshwar Meditex P/E 33.09 — signal: Overvalued. Compare with Adeshwar Meditex valuation methods to assess whether the stock is under or overvalued.
- Stock appears overvalued with PE of 33.09, suggesting caution for new investments
- Trading at discount to sector average PE of 55.0
ADESHWAR vs Healthcare Peers — P/E Ratio Comparison
Adeshwar Meditex P/E 33.09 vs Healthcare average 55.0, median 30.62 — range 2.86–706.0.
Sector Average
55.0
Sector Median
30.62
Lowest P/E
2.86
Highest P/E
706.0
Companies
198
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 2.98 | ₹52 | Low |
| Colinz Laboratories | COLINZ | 3.6 | ₹10 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.05 | ₹6,404 | Low |
| Sunrest Lifescience | SUNREST | 4.19 | ₹67 | Low |
| Shelter Pharma | SHELTER | 4.99 | ₹46 | Low |
| JFL Life Sciences | JFLLIFE | 5.83 | ₹78 | Low |
| GKB Ophthalmics | GKB | 5.94 | ₹33 | Low |
| Dipna Pharmachem | DPL | 6.52 | ₹18 | Low |
| Royal Sense | ROYAL | 6.73 | ₹48 | Low |